Sign in

or Register now

ADHDCentral.com

    See all of our health sites at www.HealthCentral.com
    Friday, November 13, 2009
    • Font size
    • Bookmark
    • Save

    "Early onset" label approved for ADHD medication

    (U.S. News and World Report) UPDATED 2008-11-18
    The U.S. Food and Drug Administration has approved a 30-minute onset of action for the ADHD drug Focalin XR. The new labeling is based on studies that showed Focalin XR improved ADHD symptoms within 30 minutes of administration when compared to a placebo.
      Read full story >
    See all ADHD News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

    Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
    Non-Profit Affiliates:
    • CHADD logo
    • Attention Deficit Disorder of America Logo
    Featuring Content From:
    • Harvard Health Publications
    • A.D.A.M.
    • Thomson PDR
    • Ivanhoe Broadcast News

    By using this service, you accept our Terms of Use. Please read them. The consumer health information on ADHDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

    This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
    • TRUSTe Certified Privacy
    • Health Care Standard of Excellence
    • FREDDIE International Health and Medical Media Award Finalist